Animation - Understanding Biomarker Testing in NSCLC
Slide Show - Understanding Biomarker Testing in NSCLC
1.
What is 'comprehensive biomarker testing'?
2.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
3.
What is a driver mutation?
4.
How is biomarker testing carried out?
5.
When should biomarker testing be done in NSCLC?
6.
Which biomarkers exist for NSCLC?
7.
What happens if my tumor tests positive? What happens if it doesn’t test positive for a biomarker?
8.
What if I have already had a biopsy and my tumor was not tested for biomarkers?
9.
What should newly diagnosed lung cancer patients do if biomarker testing is not offered to them?
10.
Why is biomarker testing so important for certain ethnic groups, such as African Americans?
11.
How can we close the gaps to make sure all NSCLC patients get tested?
Expert Video - What is a driver mutation?
Dr. Robert Winn, an expert on cancer mutations, describes the ways variations in genes can affect the course of lung cancer. He describes how knowing about specific mutations can mean knowing which medicines to use in treatment. He also discusses the difference between inherited and acquired mutations and how mutations being active may lead to cancer.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Section: Biomarker Testing in NSCLC
Expert Videos
Animation - Understanding Biomarker Testing in NSCLC
Slide Show - Understanding Biomarker Testing in NSCLC
1.
What is 'comprehensive biomarker testing'?
2.
What is comprehensive biomarker testing for lung cancer? What do I need to know?
3.
What is a driver mutation?
4.
How is biomarker testing carried out?
5.
When should biomarker testing be done in NSCLC?
6.
Which biomarkers exist for NSCLC?
7.
What happens if my tumor tests positive? What happens if it doesn’t test positive for a biomarker?
8.
What if I have already had a biopsy and my tumor was not tested for biomarkers?
9.
What should newly diagnosed lung cancer patients do if biomarker testing is not offered to them?
10.
Why is biomarker testing so important for certain ethnic groups, such as African Americans?
11.
How can we close the gaps to make sure all NSCLC patients get tested?
